MetLife, Inc. (NYSE:MET) Position Trimmed by Asset Dedication LLC

Asset Dedication LLC trimmed its holdings in shares of MetLife, Inc. (NYSE:MET) by 2.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,228 shares of the financial services provider’s stock after selling 209 shares during the period. Asset Dedication LLC’s holdings in MetLife were worth $756,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in MET. Creative Planning increased its stake in shares of MetLife by 3.1% in the second quarter. Creative Planning now owns 127,003 shares of the financial services provider’s stock worth $8,914,000 after purchasing an additional 3,865 shares during the period. NewEdge Advisors LLC lifted its position in MetLife by 1.6% during the 2nd quarter. NewEdge Advisors LLC now owns 47,203 shares of the financial services provider’s stock worth $3,313,000 after buying an additional 737 shares in the last quarter. Granite Bay Wealth Management LLC acquired a new position in MetLife during the 2nd quarter worth $585,000. Brown Financial Advisors bought a new position in MetLife in the second quarter valued at about $707,000. Finally, Sanctuary Advisors LLC acquired a new stake in MetLife during the 2nd quarter worth $6,377,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on MET. JPMorgan Chase & Co. lifted their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Wells Fargo & Company cut their target price on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. Barclays boosted their price target on MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. TD Cowen increased their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Finally, StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.46.

MetLife Stock Up 1.3 %

Shares of NYSE MET opened at $86.77 on Thursday. The company has a 50 day simple moving average of $83.95 and a 200 day simple moving average of $80.30. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 1 year low of $64.61 and a 1 year high of $89.05. The firm has a market cap of $60.08 billion, a PE ratio of 17.49, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a $0.545 dividend. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.51%. MetLife’s payout ratio is 43.95%.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.